Exact Sciences Corp
NASDAQ:EXAS

Watchlist Manager
Exact Sciences Corp Logo
Exact Sciences Corp
NASDAQ:EXAS
Watchlist
Price: 47.16 USD 3.33% Market Closed
Market Cap: 8.8B USD

Intrinsic Value

The intrinsic value of one EXAS stock under the Base Case scenario is 46.12 USD. Compared to the current market price of 47.16 USD, Exact Sciences Corp is Overvalued by 2%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EXAS Intrinsic Value
46.12 USD
Overvaluation 2%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Exact Sciences Corp

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
EXAS
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for EXAS cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Exact Sciences Corp
NASDAQ:EXAS
US
Biotechnology
Market Cap
8.8B USD
IPO
Jan 30, 2001
US
Biotechnology
Market Cap
8.8B USD
IPO
Jan 30, 2001
Price
$false
EPS
$false
AI Assistant
AI Assistant
Ask me anything about Exact Sciences Corp
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Exact Sciences Corp

Current Assets 1.6B
Cash & Short-Term Investments 1B
Receivables 249m
Other Current Assets 284.4m
Non-Current Assets 4.4B
PP&E 830.4m
Intangibles 3.4B
Other Non-Current Assets 149.9m
Efficiency

Free Cash Flow Analysis
Exact Sciences Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Exact Sciences Corp

Revenue
2.8B USD
Cost of Revenue
-840.2m USD
Gross Profit
1.9B USD
Operating Expenses
-2.1B USD
Operating Income
-179.2m USD
Other Expenses
-849.6m USD
Net Income
-1B USD
Fundamental Scores

EXAS Profitability Score
Profitability Due Diligence

Exact Sciences Corp's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
ROIC is Increasing
Positive Revenue Growth Forecast
31/100
Profitability
Score

Exact Sciences Corp's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

EXAS Solvency Score
Solvency Due Diligence

Exact Sciences Corp's solvency score is 36/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Positive Net Debt
36/100
Solvency
Score

Exact Sciences Corp's solvency score is 36/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EXAS Price Targets Summary
Exact Sciences Corp

Wall Street analysts forecast EXAS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EXAS is 68.72 USD with a low forecast of 52.52 USD and a high forecast of 89.25 USD.

Lowest
Price Target
52.52 USD
11% Upside
Average
Price Target
68.72 USD
46% Upside
Highest
Price Target
89.25 USD
89% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Exact Sciences Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for EXAS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

EXAS Insider Trading
Buy and sell transactions by insiders

EXAS News

Other Videos
What is the Intrinsic Value of one EXAS stock?

The intrinsic value of one EXAS stock under the Base Case scenario is 46.12 USD.

Is EXAS stock undervalued or overvalued?

Compared to the current market price of 47.16 USD, Exact Sciences Corp is Overvalued by 2%.

Back to Top